Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Jimmy A. Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4536-9640; OpenAlex author ID A5071917717. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 8

  1. GLIS3 marks a neural-like progenitor cell state that drives metastasis in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.celrep.2026.117314↗
  2. Integrative genomic identification of therapeutic targets for pancreatic cancer. Co-author DOI 10.1016/j.celrep.2025.116191↗
  3. The Pdgfd-Pdgfrb axis orchestrates tumor-nerve crosstalk in pancreatic cancer Co-author DOI 10.1101/2025.08.26.672505↗
  4. Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment. Co-author DOI 10.1038/s41588-024-01890-9↗
  5. Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment. Co-author DOI 10.1038/s41588-022-01134-8↗
  6. Treatment-associated remodeling of the pancreatic cancer endothelium at single-cell resolution. Co-author DOI 10.3389/fonc.2022.929950↗
  7. Refining the Molecular Framework for Pancreatic Cancer with Single-cell and Spatial Technologies. Co-author DOI 10.1158/1078-0432.ccr-20-4712↗
  8. Single-nucleus and spatial transcriptomics of archival pancreatic cancer reveals multi-compartment reprogramming after neoadjuvant treatment Co-author DOI 10.1101/2020.08.25.267336↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. William L. Hwang · 7 shared papers, 2020–2026 · strength 1.11
  2. Carina Shiau · 5 shared papers, 2022–2026 · strength 0.89
  3. Dennis H. Gong · 4 shared papers, 2024–2026 · strength 0.71
  4. Mari A. Mino-Kenudson · 4 shared papers, 2020–2026 · strength 0.59
  5. Tyler Jacks · 4 shared papers, 2020–2026 · strength 0.59
  6. Theodore Sunki Hong · 4 shared papers, 2020–2025 · strength 0.55
  7. Jennifer Yon-Li Wo · 4 shared papers, 2020–2025 · strength 0.55
  8. David Tsai Ting · 4 shared papers, 2020–2025 · strength 0.53
  9. Nicholas J Caldwell · 3 shared papers, 2024–2026 · strength 0.52
  10. Andrew J. Aguirre · 3 shared papers, 2020–2026 · strength 0.48
  11. Julien Dilly · 2 shared papers, 2025–2026 · strength 0.41
  12. Seema Chugh · 2 shared papers, 2025–2026 · strength 0.41
  13. Hannah Johnson Roberts · 2 shared papers, 2024–2025 · strength 0.30
  14. Ralph Weissleder · 2 shared papers, 2024–2025 · strength 0.30
  15. Colin D. Weekes · 2 shared papers, 2020–2021 · strength 0.23
  16. Mingjuan Lisa Zhang · 1 shared paper, 2026 · strength 0.22
  17. Brian Matthew Wolpin · 1 shared paper, 2026 · strength 0.22
  18. Jonathan Andrew Nowak · 1 shared paper, 2026 · strength 0.22
  19. Carlos F. Fernandez-del Castillo · 2 shared papers, 2020–2024 · strength 0.21
  20. Harshabad Singh · 1 shared paper, 2025 · strength 0.19
  21. Joseph Douglas Mancias · 1 shared paper, 2025 · strength 0.19
  22. Lei Zheng · 1 shared paper, 2025 · strength 0.16
  23. Peter L. Wang · 1 shared paper, 2025 · strength 0.16
  24. Lei Zheng · 1 shared paper, 2021 · strength 0.16
  25. Motaz Qadan · 1 shared paper, 2024 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.